Join the club for FREE to access the whole archive and other member benefits.

Astellas Pharma

Innovation in ophthalmology with addition of novel gene therapy program for glaucoma

Astellas Pharma US, Inc. is an affiliate of Tokyo-based Astellas Pharma Inc., a top 20 global pharmaceutical research company. Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the Americas and around the world.

Visit website: https://www.astellas.com/eu/

 AstellasUS

 astellas-pharma-us

 AstellasEMEA

Details last updated 03-Oct-2019

People at Astellas Pharma

Robert Lanza

Chief Scientific Officer at Astellas Global Regenerative Medicine

Astellas Pharma News

Mogrify and Astellas collaborate on novel gene therapy for hearing loss

Mogrify and Astellas collaborate on novel gene therapy for hearing loss

Labiotech - 17-Nov-2022

Breakthrough approach to regenerate new cochlear hair cells that enable hearing

Turn Bio raised funds to usher epigenetic reprogramming from bench to bedside

Turn Bio raised funds to usher epigenetic reprogramming from bench to bedside

Biospace - 11-Apr-2022

mRNA technology-reset aging to extend health span and improve quality of life

Topics mentioned on this page:
Gene Therapy, Vision (health)